TCR2 THERAPEUTICS INC's ticker is TCRR and the CUSIP is 87808K106. A total of 84 filers reported holding TCR2 THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 1.96 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $89,000 | -48.6% | 19,126 | -6.1% | 0.00% | -50.0% |
| Q3 2021 | $173,000 | -42.5% | 20,362 | +11.1% | 0.01% | -40.0% |
| Q2 2021 | $301,000 | -29.0% | 18,323 | -4.7% | 0.01% | -33.3% |
| Q1 2021 | $424,000 | -49.3% | 19,223 | -29.0% | 0.02% | -51.6% |
| Q4 2020 | $837,000 | +69.8% | 27,060 | +11.5% | 0.03% | +55.0% |
| Q3 2020 | $493,000 | +39.7% | 24,266 | +5.7% | 0.02% | +25.0% |
| Q2 2020 | $353,000 | +60.5% | 22,950 | -19.3% | 0.02% | +60.0% |
| Q1 2020 | $220,000 | – | 28,431 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 4,050,865 | $6,076,298 | 2.53% |
| MPM BioImpact LLC | 3,370,982 | $5,056,473 | 1.31% |
| TANG CAPITAL MANAGEMENT LLC | 3,399,745 | $5,099,618 | 0.76% |
| Newtyn Management, LLC | 1,015,920 | $1,523,880 | 0.30% |
| Artal Group S.A. | 750,000 | $1,125 | 0.07% |
| Long Focus Capital Management, LLC | 566,270 | $849,405 | 0.05% |
| Redmile Group, LLC | 658,336 | $987,504 | 0.04% |
| HARBOR CAPITAL ADVISORS, INC. | 67,642 | $101,463 | 0.03% |
| X-Square Capital, LLC | 31,720 | $48 | 0.03% |
| CORNERCAP INVESTMENT COUNSEL INC | 71,046 | $106,569 | 0.02% |